EXPERIENCE WITH THE KETOGENIC DIET IN A BOY WITH CLCN4 RELATED NEURODEVELOPMENTAL DISORDER
Sager G, Yukselmi̇s U, Güzel O, Turkyilmaz A, Akcay M
*Corresponding Author: Gunes SAGER, MD, Department of Pediatric Neurology, Kartal Dr. Lutfi Kirdar City Hospital, Semsi Denizer Avenue, Cevizli, 34890, Kartal, Istanbul, Turkey. ORCID-ID: 0000-0002-9876-2454, Tel: +905055983104, E-mail: sgunessenturk@gmail.com
page: 77
|
|
REFERENCE
1. He H, Guzman RE, Cao D, Sierra-Marquez J, Yin
F, Fahlke C, et al. The molecular and phenotypic
spectrum of CLCN4-related epilepsy. Epilepsia.
2021;62(6):1401-1415.
2. Xu X, Lu F, Zhang L, Li H, Du S, Tang J. Novel
CLCN4 variant associated with syndromic X-linked
intellectual disability in a Chinese girl: a case report.
BMCPediatr. 2021;3;21(1):384.
3. Weinert S, Gimber N, Deuschel D, Stuhlmann T,
Puchkov D, Farsi Z, et al. Uncoupling endosomal
CLC chloride/proton exchange causes severe neu-
rodegeneration. EMBO J.2020;4;39(9):e103358.
4. Palmer EE, Pusch M, Picollo A, Forwood C, Nguyen MH., et al. Functional and clinical studies reveal
pathophysiological complexity of CLCN4-related
neurodevelopmental condition. Mol Psychiatry. 2023
Feb;28(2):668-697.
5. Bough KJ, Rho JM. Anticonvulsant mechanisms of
the ketogenic diet. Epilepsia. 2007 Jan;48(1):43-58.
6. Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil
KR, Christina Bergqvist AG., et al. Charlie Founda-
tion; Matthew’s Friends; Practice Committee of the
Child Neurology Society. Optimal clinical manage-
ment of children receiving dietary therapies for epilepsy: Updated recommendations of the International
Ketogenic Diet Study Group. Epilepsia Open. 2018
May 21;3(2):175-192.
7. Zhou P, He N, Zhang JW, Lin ZJ, Wang J, Yan LM,
et al. Novel mutations and phenotypes of epilepsy-
associated genes in epileptic encephalopathies. Genes
Brain Behav. 2018;17(8):e12456.
8. Archila R, Papazian O. Síndrome de Lennox-Gastaut
[Lennox-Gastaut syndrome].Rev Neurol. 1999;16-
31;29(4):346-9. Spanish.
9. Accardi A, Miller C. Secondary active transport medi-
ated by a prokaryotic homologue of ClC Cl- channels.
Nature. 2004:26;427(6977):803-7.
10. Guzman RE, Alekov AK, Filippov M, Hegermann
J, Fahlke C. Involvement of ClC-3chloride/proton
exchangers in controlling glutamatergic synaptic
strength incultured hippocampal neurons. Front Cell
Neurosci. 2014;23;8:143.
11. Veeramah KR, Johnstone L, Karafet TM, Wolf D,
Sprissler R, Salogiannis J, et al. Exome sequencing
reveals new causal mutations in children with epileptic encephalopathies. Epilepsia. 2013;54(7):1270-81.
12. Fernández-Marmiesse A, Roca I, Díaz-Flores F, Can-
tarín V, Pérez-Poyato MS,Fontalba A, Laranjeira F,
et al. Rare Variants in 48 Genes Account for42% of
Cases of Epilepsy With or Without Neurodevelopmental Delay in 246Pediatric Patients. Front Neuro-
sci. 2019:8;13:1135.
13. Tassinari CA, Dravet C, Roger J, Cano JP, Gastaut H.
Tonic status epilepticus precipitated by intravenous
benzodiazepine in five patients with Lennox-Gastaut
syndrome. Epilepsia. 1972 Jul;13(3):421-35.
14. Sankar R. GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. CNS Drugs. 2012;26(3):229-44.
15. Macdonald RL, Kelly KM. Antiepileptic drug mecha-
nisms of action. Epilepsia.1995;36l 2:S2-12.
16. Palmer EE, Stuhlmann T, Weinert S, Haan E, Van
Esch H, Holvoet M, et al. De novo and inherited
mutations in the X-linked gene CLCN4 are associated
with syndromic intellectual disability and behavior
and seizure disorders in males and females. Mol Psychiatry. 2018 ;23(2):222-230.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
